. . . . . . . "[This cell line and its orthotopic xenograft models were exposed to p110?-specific inhibitor BYL719, p110?-specific inhibitor AZD6482, or pan-PI3K inhibitor BKM120, respectively, and the results showed sensitivity to both BYL719 and BKM120 but not AZD6482, which indicated a p110?-reliance for HER2-positive-PTEN-loss breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:23+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .